Electronic National Residential Medication Chart - Round 2

Overview

The Australian Government has made up to $30 million (GST Exclusive) available for the eNRMC Adoption grant opportunity, under the Supporting Medication Management in Residential Aged Care Initiative. The desired outcome of the grant opportunity is to increase the use of eNRMC products in Residential Aged Care Services (RACS), National Aboriginal and Torres Strait Islander Flexible Aged Care (NATSIFAC) residential services and multi-purpose services (MPSs) that provide residential aged care services. The use of eNRMC products provide significant benefits to Australians within these settings, improving health outcomes by enhancing quality use of medicines, improved medication management and medication safety practices. Through real-time medication ordering and administration recording, an eNRMC system enables aged care staff, prescribers, and suppliers to reduce medication errors and gain greater flexibility and coordination in the way their services are delivered. It also supports consumer-centred care and enhances communication between all those supporting the resident’s clinical care. The grant opportunity is designed to help defray the costs associated with implementing a conformant eNRMC product, such as software and hardware costs, change management processes and staff training. Grant recipients will have 12 months from the date of their grant agreement to adopt a conformant product. A conformant eNRMC product is one that meets all state/territory requirements and is either: an Electronic Prescribing Conformant eNRMC product listed on the Electronic Prescribing Conformance Register; or approved by the Australian Digital Health Agency (the Agency) as a Transitional eNRMC Product and listed on the Transitional eNRMC Conformance Register. To view the grant opportunity documents, please select the red "GO Documents" button on the left-hand side.